Isabelle Groß

3.1k total citations
39 papers, 1.6k citations indexed

About

Isabelle Groß is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Isabelle Groß has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Genetics and 9 papers in Oncology. Recurrent topics in Isabelle Groß's work include Digestive system and related health (13 papers), Epigenetics and DNA Methylation (6 papers) and Cancer Cells and Metastasis (4 papers). Isabelle Groß is often cited by papers focused on Digestive system and related health (13 papers), Epigenetics and DNA Methylation (6 papers) and Cancer Cells and Metastasis (4 papers). Isabelle Groß collaborates with scholars based in France, United States and Germany. Isabelle Groß's co-authors include Jonathan D. Licht, Miriam Benezra, Bhramdeo Bassit, Jean‐Noël Freund, Christian Gaiddon, Elisabeth Martin, Isabelle Duluc, Patricia D. Wilson, M. Kédinger and Jean‐Philippe Loeffler and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Isabelle Groß

39 papers receiving 1.6k citations

Peers

Isabelle Groß
Alfred A. Reszka United States
Francis Jacob Switzerland
Ruiying Zhao United States
Peter Ruminski United States
Thomas J. Owen United Kingdom
Patrick C. Elwood United States
Inder Sehgal United States
Isabelle Groß
Citations per year, relative to Isabelle Groß Isabelle Groß (= 1×) peers Taichi Kimura

Countries citing papers authored by Isabelle Groß

Since Specialization
Citations

This map shows the geographic impact of Isabelle Groß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Groß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Groß more than expected).

Fields of papers citing papers by Isabelle Groß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Groß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Groß. The network helps show where Isabelle Groß may publish in the future.

Co-authorship network of co-authors of Isabelle Groß

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Groß. A scholar is included among the top collaborators of Isabelle Groß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Groß. Isabelle Groß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Groß, Isabelle, et al.. (2025). Social interaction in different contexts of screen-media activities: The case of Chinese-heritage children and caregivers in Taiwan. Journal of Children and Media. 19(4). 793–812. 1 indexed citations
2.
Delhorme, Jean‐Baptiste, Chloé Terciolo, Elisabeth Martin, et al.. (2022). CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer. Biomedicine & Pharmacotherapy. 147. 112630–112630. 9 indexed citations
3.
Hou, Lidan, Yichao Hou, Yu Liang, et al.. (2022). Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer. Communications Biology. 5(1). 1248–1248. 11 indexed citations
4.
Terciolo, Chloé, et al.. (2021). Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms. Biomedicine & Pharmacotherapy. 146. 112543–112543. 11 indexed citations
5.
Mellitzer, Georg, Elisabeth Martin, Laëtitia Marisa, et al.. (2020). The atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanisms. Oncogene. 40(3). 522–535. 8 indexed citations
6.
Licona, Cynthia, Jean‐Baptiste Delhorme, Ricardo Cerón‐Camacho, et al.. (2019). Anticancer activity of ruthenium and osmium cyclometalated compounds: identification of ABCB1 and EGFR as resistance mechanisms. Inorganic Chemistry Frontiers. 7(3). 678–688. 36 indexed citations
7.
Vanier, Marie T., Olivier Armant, Elisabeth Martin, et al.. (2017). Fine-tuning and autoregulation of the intestinal determinant and tumor suppressor homeobox gene CDX2 by alternative splicing. Cell Death and Differentiation. 24(12). 2173–2186. 11 indexed citations
8.
Platet, Nadine, Ludovic Richert, Devadarssen Murdamoothoo, et al.. (2016). The tumor suppressor CDX2 opposes pro-metastatic biomechanical modifications of colon cancer cells through organization of the actin cytoskeleton. Cancer Letters. 386. 57–64. 29 indexed citations
9.
Palamiuc, Lavinia, Samir Benosman, Sophie B. Mériaux, et al.. (2016). Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63. eLife. 5. 29 indexed citations
10.
Modica, Salvatore, Annalisa Morgano, Isabelle Groß, et al.. (2014). Transcriptional Regulation of the Intestinal Nuclear Bile Acid Farnesoid X Receptor (FXR) by the caudal-related Homeobox 2 (CDX2). Journal of Biological Chemistry. 289(41). 28421–28432. 14 indexed citations
11.
Benosman, Samir, Xiangjun Meng, Lavinia Palamiuc, et al.. (2011). Complex Regulation of p73 Isoforms after Alteration of Amyloid Precursor Polypeptide (APP) Function and DNA Damage in Neurons. Journal of Biological Chemistry. 286(50). 43013–43025. 27 indexed citations
12.
Renouf, Benjamin, François Delalande, Elisabeth Martin, et al.. (2011). Cdx2 homeoprotein inhibits non-homologous end joining in colon cancer but not in leukemia cells. Nucleic Acids Research. 40(8). 3456–3469. 20 indexed citations
13.
Meng, Xiangjun, Marjorie Jenny, Isabelle Groß, et al.. (2009). A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth through Induction of the Endoplasmic Reticulum Stress Gene CHOP. Cancer Research. 69(13). 5458–5466. 190 indexed citations
14.
Cademartiri, Rebecca, et al.. (2009). Immobilization of bacteriophages on modified silica particles. Biomaterials. 31(7). 1904–1910. 91 indexed citations
15.
Groß, Isabelle, Stephen J. Gaunt, Felix Beck, et al.. (2008). Multiple Regulatory Regions Control the Complex Expression Pattern of the Mouse Cdx2 Homeobox Gene. Gastroenterology. 135(4). 1238–1247.e3. 70 indexed citations
16.
Turck, Natacha, Olivier Lefèbvre, Isabelle Groß, et al.. (2005). Effect of laminin‐1 on intestinal cell differentiation involves inhibition of nuclear nucleolin. Journal of Cellular Physiology. 206(2). 545–555. 40 indexed citations
17.
Basson, M. Albert, Judy Watson-Johnson, Ruth Simon, et al.. (2005). Sprouty1 Is a Critical Regulator of GDNF/RET-Mediated Kidney Induction. Developmental Cell. 8(2). 229–239. 284 indexed citations
18.
Groß, Isabelle, Bhramdeo Bassit, Miriam Benezra, & Jonathan D. Licht. (2001). Mammalian Sprouty Proteins Inhibit Cell Growth and Differentiation by Preventing Ras Activation. Journal of Biological Chemistry. 276(49). 46460–46468. 215 indexed citations
19.
Hosono, Seiyu, Isabelle Groß, Milton A. English, et al.. (2000). E-cadherin Is a WT1 Target Gene. Journal of Biological Chemistry. 275(15). 10943–10953. 104 indexed citations
20.
Groß, Isabelle, Philippe Georgel, Pascale Oertel‐Buchheit, Manfred Schnarr, & Jean‐Marc Reichhart. (1999). Dorsal-B, a splice variant of the Drosophila factor Dorsal, is a novel Rel/NF-κB transcriptional activator. Gene. 228(1-2). 233–242. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026